Cargando…
Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
INTRODUCTION: Cardiac amyloidosis is the most common cause of infiltrative cardiomyopathy and is associated with a poor prognosis. Transthyretin cardiac amyloidosis, particularly the type caused by the mutation that replaces the amino acid valine with the amino acid isoleucine at position 122 (Val12...
Autores principales: | Molina O, Gabriela, Judge, Daniel, Campbell, Wayne, Chahal, Harjit, Mugmon, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246150/ https://www.ncbi.nlm.nih.gov/pubmed/25432650 http://dx.doi.org/10.3402/jchimp.v4.25500 |
Ejemplares similares
-
Transthyretin Cardiac Amyloidosis: Pathogenesis, Treatments, and Emerging Role in Heart Failure with Preserved Ejection Fraction
por: Ton, Van-Khue, et al.
Publicado: (2015) -
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
por: Gonzalez-Lopez, Esther, et al.
Publicado: (2022) -
The Role of Imaging in Diagnosing Transthyretin Cardiac Amyloidosis
por: Chaaban, Nourhan, et al.
Publicado: (2021) -
Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis
por: Palot Manzil, Fathima Fijula, et al.
Publicado: (2023) -
Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)